nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of incidence of thrombotic complications in the presence of competing risks
|
Mainbourg, Sabine |
|
|
191 |
C |
p. 152 |
artikel |
2 |
Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119)
|
Beyer-Westendorf, Jan |
|
|
191 |
C |
p. 50-55 |
artikel |
3 |
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
|
Brüggemann, Renée |
|
|
191 |
C |
p. 153-155 |
artikel |
4 |
Arterial and venous thrombosis: What's the link? A narrative review
|
Delluc, Aurélien |
|
|
191 |
C |
p. 97-102 |
artikel |
5 |
Assessing the hemostasis with thromboelastometry in direct oral anticoagulants-treated patients with atrial fibrillation
|
Korpallová, Barbora |
|
|
191 |
C |
p. 38-41 |
artikel |
6 |
Cerebral infarction and iron deficiency anemia due to uterine myoma in two middle-aged women with histidine-rich glycoprotein deficiency
|
Shigekiyo, Toshio |
|
|
191 |
C |
p. 30-33 |
artikel |
7 |
Cloning, purification and characterization of a recombinant protease with novel thrombolytic activity in human plasma and rat thrombosis models
|
Lim, Do Sung |
|
|
191 |
C |
p. 57-65 |
artikel |
8 |
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE
|
Bounameaux, Henri |
|
|
191 |
C |
p. 103-112 |
artikel |
9 |
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
|
Klok, F.A. |
|
|
191 |
C |
p. 148-150 |
artikel |
10 |
Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]
|
Mulder, F.I. |
|
|
191 |
C |
p. 156-159 |
artikel |
11 |
COVID-19 associated pulmonary thrombosis
|
van Nieuwkoop, C. |
|
|
191 |
C |
p. 151 |
artikel |
12 |
D-dimer as a stand-alone test to rule out deep vein thrombosis
|
Rinde, Fridtjof B. |
|
|
191 |
C |
p. 134-139 |
artikel |
13 |
Debate: Thromboprophylaxis should be considered in all patients with cancer - No
|
van Es, Nick |
|
|
191 |
C |
p. 34-35 |
artikel |
14 |
Debate: Thromboprophylaxis should be considered in all patients with cancer – Yes
|
Carrier, M. |
|
|
191 |
C |
p. 142-144 |
artikel |
15 |
Developing a model for predicting venous thromboembolism in obese pregnant women in a national study
|
Ellis-Kahana, Julia |
|
|
191 |
C |
p. 42-49 |
artikel |
16 |
Editorial Board
|
|
|
|
191 |
C |
p. IFC |
artikel |
17 |
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention
|
Jung, Richard G. |
|
|
191 |
C |
p. 125-133 |
artikel |
18 |
Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants
|
Evrard, J. |
|
|
191 |
C |
p. 78-81 |
artikel |
19 |
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes
|
Ziliotto, Nicole |
|
|
191 |
C |
p. 113-124 |
artikel |
20 |
Fibrinogen, factor XIII and α2-antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies
|
Hoppe, Berthold |
|
|
191 |
C |
p. 90-96 |
artikel |
21 |
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency
|
Rugeri, Lucia |
|
|
191 |
C |
p. 22-25 |
artikel |
22 |
Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study
|
Overvad, Thure Filskov |
|
|
191 |
C |
p. 1-8 |
artikel |
23 |
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
|
Klok, F.A. |
|
|
191 |
C |
p. 145-147 |
artikel |
24 |
Increased prevalence of VTE reported by Klok and colleagues, the numbers don't add up
|
Greenstein, Yonatan Y. |
|
|
191 |
C |
p. 28 |
artikel |
25 |
Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry
|
Nishimoto, Yuji |
|
|
191 |
C |
p. 66-75 |
artikel |
26 |
Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism
|
Johnsen, Håkon S. |
|
|
191 |
C |
p. 82-89 |
artikel |
27 |
Pulmonary embolism in a young pregnant woman with COVID-19
|
Martinelli, Ida |
|
|
191 |
C |
p. 36-37 |
artikel |
28 |
TEG in pregnancy: Current challenges and future potential applications
|
Amgalan, Ariunzaya |
|
|
191 |
C |
p. 140-141 |
artikel |
29 |
The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
|
Mozzini, Chiara |
|
|
191 |
C |
p. 26-27 |
artikel |
30 |
The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome
|
Gando, Satoshi |
|
|
191 |
C |
p. 15-21 |
artikel |
31 |
Thrombotic complications in critically ill patients with COVID 19
|
Rosen, Raphael J. |
|
|
191 |
C |
p. 56 |
artikel |
32 |
Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
|
Thomas, W. |
|
|
191 |
C |
p. 76-77 |
artikel |
33 |
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
|
Lodigiani, Corrado |
|
|
191 |
C |
p. 9-14 |
artikel |
34 |
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
|
Ciavarella, Alessandro |
|
|
191 |
C |
p. 29 |
artikel |